Benzinga··Vandana SinghEli Lilly's Jaypirca Notches Fourth Phase 3 Win, Strengthening Blood Cancer Portfolio
Eli Lilly reports fourth positive Phase 3 trial for Jaypirca in chronic lymphocytic leukemia, positioning drug for label expansion ahead of competitive launches.
JNJABBVLLYPhase 3 trialprogression-free survival